Introducing the Comprehensive SLT e-Book

Introducing the Comprehensive SLT e-Book

See what SLT experts have to say about the role this technology plays in clinical practice by downloading your FREE e-book.

Since SLT’s U.S. introduction in 2001, volumes of research have been conducted to demonstrate its effectiveness as a primary therapy for glaucoma. Ellex has gathered experts from across the globe to share their knowledge and vast experience in one exhaustive e-book encompassing everything you need to know about SLT.

In-depth interviews, helpful charts and graphs, enlightening videos, extensive white papers, and supplementary SLT resources geared toward physicians, clinics, and patients alike are all embedded within the educational e-book’s 96 pages. Featured topics include:

• Solving the glaucoma patient compliance conundrum

• Bringing down cost of glaucoma treatment

• Delivering results that stand the test of time

• Benefits of SLT as a primary therapy

What the Experts Are Saying

	Lawrence Jindra, MD, and his colleagues have analyzed data gathered from more than 4000 patients to find a cumulative probability of success of over 90% at 10 years if SLT is used as the primary therapy. Their data revealed that 57% of patients referred for SLT while taking medications end up taking no medication at all after their SLT treatment.
	“The long-term efficacy provided by SLT means that patients gain a new lease on life because they no longer feel chained to a never-ending supply of medications.” – Lawrence Jindra, MD
	“It takes time to change practice patterns, but now it seems that the mindset has shifted on SLT because of the growing body of evidence that points to its safety and efficacy when used as a primary treatment.” – Andrew Iwach, MD
	“SLT takes pressure control out of the hands of the patient and puts it back in the hands of the ophthalmologist. If I were making a decision on glaucoma treatment for my family or myself, I would certainly choose SLT.” – Madhu Nagar, MD
	“I give my patients the option to undergo SLT or commence treatment with eye drops. More than 98% select SLT.” – Philip Paden, MD
	“Since SLT is more economical than medications, ophthalmologists prescribing SLT may be more attractive to healthcare plans.” – Randy Craven, MD